Evaluation of a multilayered chitosan-hydroxy-apatite porous composite enriched with fibronectin or an in vitro-generated bone-like extracellular matrix on proliferation and diferentiation of osteoblasts

Journal of Tissue Engineering and Regenerative Medicine

Volumn 6, Issue 6, 2012, Pages 497-504

  Fernandez M S ^a   Arias, J I ^a   Martinez M J ^a   Saenz, L ^a   Neira Carrillo, A ^a   Yazdani Pedram, M ^a   Arias, J L ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Alkaline phosphatase; Chitosan hydroxyapatite; Composite; Extracellular matrix; Fibronectin; Scaffold

Indexed keywords

BONE; CELL PROLIFERATION; CHITOSAN; MOLECULES; OSTEOBLASTS; PHOSPHATASES; PHOSPHATE MINERALS; SCAFFOLDS (BIOLOGY);

ALKALINE PHOSPHATASE; CHITOSAN-HYDROXYAPATITE; COMPOSITE SCAFFOLDS; EXTRACELLULAR MATRICES; EXTRACELLULAR MATRIX MOLECULES; HYDROXY APATITES; IN-VITRO; MULTI-LAYERED; OSTEOPROGENITOR CELLS; POROUS COMPOSITES;

HYDROXYAPATITE;

ALKALINE PHOSPHATASE; CHITOSAN; FIBRONECTIN; HYDROXYAPATITE; MOLECULAR SCAFFOLD;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; COMPOSITE GRAFT; COMPOSITE MATERIAL; CONTROLLED STUDY; ENRICHMENT CULTURE; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; OSTEOBLAST; POROSITY; PRIORITY JOURNAL;

EID: 84860680745     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.455     Document Type: Article

References (56)

1. Amato I, Ciapettia G, Pagani S, et al. 2007; Expression of cell adhesion receptors in human osteoblasts cultured on biofunctionalized poly(ε-caprolactone) surfaces. Biomaterials 28: 3668-3678.
2. Arias JI. 2008; Diseño, elaboración y evaluación de una nueva biocerámica compósita multilaminar para implante óseo [Design, fabrication and evaluation of a multilayered composite bioceramic for bone graft]. PhD Thesis, University of Chile.
3. Arias JI, Neira-Carrillo A, Yazdani-Pedram M, et al. 2009; A new multilayered composite bioceramic for bone graft. In Structure-Property Relationships in Biomineralized and Biomimetic Composites, Kisailus D, Estroff L, Landis W, et al. (eds). Materials Research Society Symposium Proceedings, vol. 1187. Warrendale, PA, USA; KK09-02.
4. Caplan AI. 2009; New era of cell-based orthopaedic therapies. Tissue Eng B 15: 195-200.
5. Chen JD, Wang YJ, Chen XF, et al. 2009; Biomimetic synthesis of porous composite scaffold composed of nano-hydroxyapatite and chitosan by freeze-drying technology. Rare Metal Mater Eng 30: 271-273.
6. Chen JD, Nan KH, Yin SH, et al. 2010; Characterization and biocompatibility of nanohybrid scaffold prepared via in situ crystallization of hydroxyapatite in chitosan matrix. Colloids Surf B Interf 81: 640-647.
7. Chesnutt BM, Yuan YL, Buddington K, et al. 2009; Composite chitosan/nano-hydroxyapatite scaffolds induce osteocalcin production by osteoblasts in vitro and support bone formation in vivo. Tissue Eng A 15: 2571-2579.
8. Custodio CA, Alves CM, Reis RL, et al. 2010; Immobilization of fibronectin in chitosan substrates improves cell adhesion and proliferation. J Tissue Eng Reg Med 4: 316-323.
9. Datta N, Holtorf HL, Sikavitsas VI, et al. 2005; Effect of bone extracellular matrix synthesized in vitro on the osteoblastic differentiation of marrow stromal cells. Biomaterials 26: 971-977.
10. Dennis JE, Caplan AI. 1993; Porous ceramic vehicles for rat-marrow derived (Rattus norvegicus) osteogenic cell delivery: effects of pre-treatment with fibronectin or laminin. J Oral Implantol 19: 106-115.
11. Dennis JE, Haynesworth SE, Young RG, et al. 1992; Osteogenesis in marrow-derived mesenchymal cell porous ceramic composites transplanted subcutaneously: effect of fibronectin and laminin on cell retention and rate of osteogenic expression. Cell Transpl 1: 23-32.
12. Dennis JE, Konstantakos EK, Caplan AI. 1998; In vivo osteogenesis assay: a rapid method for quantitative analysis. Biomaterials 19: 1322-1328.
13. Deville S, Saiz E, Nalla RK, et al. 2006; Freezing as a path to build complex composites. Science 311: 515-518.
14. Falini G, Fermani S, Ripamonti A. 2001; A Oriented crystallization of octacalcium phosphate into β-chitin scaffold. J Inorg Biochem 84: 255-258.
15. Garcia AJ, Reyes CD. 2005; Bio-adhesive surfaces to promote osteoblasts differentiation and bone formation. J Dent Res 84: 407-413.
16. Garcia AJ, Ducheyne P, Boettiger D. 1997; Cell adhesion strength increases linearly with adsorbed fibronectin surface density. Tissue Eng 3: 197-206.
17. Ge Z, Baguenard S, Lim LY, et al. 2004; Hydroxyapatite-chitin materials as potential tissue engineered bone substitutes. Biomaterials 25: 1049-1058.
18. Globus RK, Doty SB, Lull JC, et al. 1998; Fibronectin is a survival factor for differentiated osteoblasts. J Cell Sci 111: 1385-1393.
19. Gronthos S, Simmons PJ, Graves SE, et al. 2001; Integrin-mediated interactions between human bone marrow stromal precursor cells and the extracellular matrix. Bone 28: 174-181.
20. Gomes ME, Sikavitsas VI, Behravesh E, et al. 2003; Effect of flow perfusion on the osteogenic differentiation of bone marrow stromal cells cultured on starch-based three-dimensional scaffolds. J Biomed Mater Res 67A: 87-95.
21. Hamidouche Z, Fromigue O, Ringe J, et al. 2009; Priming integrin α5 promotes human mesenchymal stromal cell osteoblast differentiation and osteogenesis. Proc Nat Acad Sci USA 106: 18587-18591.
22. Hidalgo-Bastida LA, Cartmell SH. 2010; Mesenchymal stem cells, osteoblasts and extracellular matrix proteins: enhancing cell adhesion and differentiation for bone tissue engineering. Tissue Eng 16: 405-412.
23. Ho MH, Kuo PY, Hsieh HJ, et al. 2004; Preparation of porous scaffolds by using freeze-extraction and freeze-gelation methods. Biomaterials 25: 129-138.
24. Hsieh CY, Tsai SP, Ho MH, et al. 2007; Analysis of freeze-gelation and cross-linking processes for preparing porous chitosan scaffolds. Carbohyd Polym 67: 124-132.
25. Ho MH, Wang DM, Hsieh HJ, et al. 2005; Preparation and characterization of RGD-immobilized chitosan scaffolds. Biomaterials 26: 3197-3206.
26. Keselowsky BG, Wang I, Schwartz Z, et al. 2007; Integrin-α(5) controls osteoblastic proliferation and differentiation responses to titanium substrates presenting different roughness characteristics in a roughness independent manner. J Biomed Mater Res 80A: 700-710.
27. Lee YM, Park YJ, Lee SJ, et al. 2000; Tissue engineered bone formation using chitosan/tricalcium phosphate sponges. J Periodontol 71: 410-417.
28. Lu Y, Zhu AP, Wang WP, et al. 2010; New bioactive hybrid material of nano-hydroxyapatite based on N-carboxyethylchitosan for bone engineering. Appl Surf Sci 256: 7228-7233.
29. Ma J, Wang H, He B, et al. 2001; A preliminary in vitro study on the fabrication and tissue engineering application of a novel chitosan bilayer material as a scaffold of human neofetal fibroblast. Biomaterials 22: 331-336.
30. Ma PX, Zhang R, Xiao G, et al. 2001; Engineering new bone tissue in vitro on highly porous poly(α-hydroxyl acids)/hy-droxyapatite composite scaffolds. J Biomed Mater Res 54: 284-293.
31. Malafaya PP, Pedro AJ, Peterbauer A, et al. 2005; Chitosan particles agglomerated scaffolds for cartilage and osteochondral tissue engineering approaches with adipose tissue derived stem cells. J Mater Sci Mater Med 16: 1077-1085.
32. Marletta G, Ciapetti G, Satriano C, et al. 2005; The effect of irradiation modification and RGD sequence adsorption on the response of human osteoblasts to polycaprolactone. Biomaterials 26: 4793-4804.
33. Martino MM, Mochizuki M, Rothenfluh DA, et al. 2009; Controlling integrin specificity and stem cell differentiation in 2D and 3D environments through regulation of fibronectin domain stability. Biomaterials 30: 1089-1097.
34. Moursi AM, Winnard AV, Winnard PL, et al. 2002; Enhanced osteoblast response to a polymethylmethacrylate-hydroxyapatite composite. Biomaterials 3: 133-144.
35. Muhonen V, Fauveaux C, Olivera G, et al. 2009; Fibronectin modulates osteoblast behavior on Nitinol. J Biomed Mat Res A 88A: 787-796.
36. Oliveira JM, Rodrigues MT, Silva SS, et al. 2006; Novel hydroxyapatite/chitosan bilayered scaffold for osteochondral tissue engineering applications: scaffold design and its performance when seeded with goat bone marrow stromal cells. Biomaterials 27: 6123-6137.
37. Ong JI, Bess EG, Bessho K. 1999; Osteoblast progenitor cell responses to characterized titanium surfaces in the presence of bone morphogenetic protein-atelopeptide type I collagen in vitro. J Oral Implantol 25: 95-100.
38. Ozawa S, Kasugai S. 1996; Evaluation of implant materials (hydroxyapatite, glass-ceramics, titanium) in rat bone marrow stromal cell culture. Biomaterials 17: 23-29.
39. Pankov R, Yamada KM. 2002; Fibronectin at a glance. J Cell Sci 115: 3861-3863.
40. Petrie TA, Raynor JE, Reyes CD, et al. 2008; The effect of integrin-specific bioactive coatings on tissue healing and implant osteointegration. Biomaterials 29: 2849-2857.
41. Pham QP, Kasper FK, Baggett LS, et al. 2008; The influence of an in vitro generated bone-like extracellular matrix on osteoblastic gene expresión of marrow stromal cells. Biomaterials 29: 2729-2739.
42. Roehlecke C, Witt M, Kasper M, et al. 2001; Synergistic effect of titanium alloy and collagen type I on cell adhesion, proliferation and differentiation of osteoblast-like cells. Cells Tissues Organs 168: 178-187.
43. Shin H, Jo S, Mikos AG. 2003; Biomimetic materials for tissue engineering. Biomaterials 24: 4353-4364.
44. Shu R, McMullen R, Baumann MJ, et al. 2003; Hydroxyapatite accelerates differentiation and suppresses growth of MC3T3-E1 osteoblasts. J Biomed Mater Res 67: 1196-1204.
45. Sogo Y, Ito A, Matsuno T, et al. 2007; Fibronectin-calcium phosphate composite layer on hydroxyapatite to enhance adhesion, cell spread and osteogenic differentiation of human mesenchymal stem cells in vitro. Biomed Mater 2: 116-123.
46. Stephanson SN, Byers BA, Garcia AJ. 2002; Enhanced expression of the osteoblstic phenotype on substrates that modulate fibronectin conformation and integrin receptor binding. Biomaterials 23: 2527-2534.
47. Su WB, Sun KY, Chu CL, et al. 2009; The behavior of rhBMP2 gene transfecting cells on nanometer hydroxyapatite/chitosan scaffold. J Med Biol Engin 29: 290-295.
48. Teng SH, Lee EJ, Yoon BH, et al. 2009; Chitosan/nanohydroxyapatite composite membrane via dynamic filtration for guided bone regeneration. J Biomed Mater Res A 88A: 569-580.
49. Tigli RS, Gumusderelioglu M. 2008; Evaluation of RGD- or EGF-immobilized chitosan scaffolds for chondrogenic activity. Int Biol Macromol 43: 121-128.
50. Tsutsumi H, Pugdee K, Hayakawa T, et al. 2009; Discoidin domain receptor-1 gene expression of osteoblsts on fibronectin-coated titanium disks. J Hard Tissue Biol 18: 13-18.
51. Wan Y, Creber K, Peppely B, et al. 2003; Synthesis, characterization and ionic conductive properties of phosphorylated chitosan membranes. Macromol Chem Phys 204: 850-858.
52. Von Walter M, Ruger M, Ragoss C, et al. 2005; In vitro behavior of a porous Ti = 2/perlite composite and its surface modification with fibronectin. Biomaterials 26: 2813-2826.
53. Weir MD, Xu HHK. 2010; Osteoblastic induction on calcium phosphate cement-chitosan constructs for bone tissue engineering. J Biomed Mater Res A 94A: 223-233.
54. Wu T, Nan KH, Chen JD, et al. 2009; A new bone repair scaffold combined with chitosan/hydroxyapatite and sustained releasing icariin. Chin Sci Bull 54: 2953-2961.
55. Yazdani-Pedram M, Tapia C, Retuert J, et al. 2003; Synthesis and unusual swelling behavior of combined cationic/non-ionic hydrogels based on chitosan. Macromol Biosci 3: 577-581.
56. Zheng ZH, Wei YJ, Wang G, et al. 2009; Surface characterization and cytocompatibility of three chitosan/polycation composite membranes for guided bone regeneration. J Biomat Appl 24: 209-229.